Advertisement

Legislative negotiators agree on opioid bill

This Aug. 29, 2018 photo shows an arrangement of prescription Oxycodone pills in New York. Photo: AP Photo/Mark Lennihan
This Aug. 29, 2018 photo shows an arrangement of prescription Oxycodone pills in New York.

May 20, 2019 06:00 PM

A House-Senate conference committee has reached a bipartisan agreement on compromise legislation aimed at stopping Minnesota's opioid crisis.

The bill imposes sharply higher registration fees on drug makers and distributors to raise around $21 million annually. Part of the money would go for grants to fund prevention strategies to reduce opioid deaths and overdoses.

Advertisement

Related: Minnesota Senate and House pass bill aimed at drug prices

Much of the rest would go to counties to help reimburse them for their growing child protection costs resulting from families being hurt by the opioid crisis.

Under the compromise, the registration fees would end once the state recovers at least $250 million from settlements with drug makers after a minimum of five years. House negotiators wanted those fees to be permanent, while Senate conferees insisted on the sunset. Settlement revenues would go to response efforts.

Connect with KSTP


Join the conversation on our social media platforms. Share your comments on our Facebook, Instagram, and Twitter pages.

Credits

Associated Press

(Copyright 2019 by The Associated Press. All Rights Reserved.)

Advertisement

Fed cuts key interest rate again

Minnesota opioid task force to hold 1st meeting next week

St. Paul police budget presentation to include push for more officers

Magistrate: Mosque bombing case should not be dismissed

Woman killed in Pine County house fire

Lakeland City Council strips mayor of some powers

Advertisement